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The theta antigen, described by Reif and Allen (1),  provides a  marker for 
thymus-derived lymphocytes in the  mouse. The uses of  this  antigen system 
for studies in numerous fields, including immune system development, cellular 
cooperation, and the distribution of lymphocyte subpopulations, have recently 
been reviewed  (2).  Expression  of  the  theta  antigen is  governed by  a  single 
autosomal locus having two alleles, 0 aKR  and 0 c3~ (3). 
After immunization  with 0-AKR antigen-bearing  cells, spleen cells harvested 
from mice homozygous for 0c3~ have been shown to form plaques against thy- 
mus cells from several inbred rat strains as well as against those of mice carry- 
ing the 0  aKR  allele (4). The present study was undertaken in order to clarify 
the relationship between this rat antigen system and the 0-system of mice. 
Materials and Methods 
Animals.--All inbred rat strains used in this study were obtained from Microbiological 
Associates, Inc., Bethesda, Md., with the exception of strain DA which was kindly provided 
by Dr. Joy Palm, The Wistar Institute, Philadelphia, Pa., and strain D which was originated 
in this laboratory by Dr. Ray D. Owen. AKR/J and C3H/HeJ mice were bought from the 
lackson Laboratory, Bar Harbor, Maine, and AKR/Cum mice came from Cumberland View 
Farms, Clinton, Tenn. 
Anti-O  Sera.--Antisera were produced  according to  the optimal  schedule described by 
Reif and Allen (3). Blood was collected from the tail into heparinized tubes, and the plasma 
stored at --20~C until used. 
Cytotoxicity Assay.--The cytotoxic test  employed was similar to the one-step microcyto- 
toxicity assay described by Amos (5), except for the substitution of Hanks' balanced salt 
solution (HBSS)1 for barbital buffer in the thymocyte  (TC) suspension, and of 0.3% trypan 
blue in HBSS for 0.25% trypan blue in saline. Test cells were preincubated with antiserum for 
15  rain at  room temperature  before complement addition.  Test plates  (No. 3034; Falcon 
Plastics, Div. B-D Laboratories,  Inc., Los Angeles, Calif.) were then further  incubated for 
20 rain at 37°C in a 6.3% CO2 atmosphere. Exclusion of trypan blue dye was then used as the 
measure of test cell viability. 
Complement.--Rabbit  serum diluted 1/3 in HBSS (from which Ca  ++ and Mg  ++ had been 
omitted)  was absorbed with purified agarose (Bio-Rad Laboratories,  Richmond, Calif.) at 
0°C for 30 min in the presence of 0.01 ~  ethylenediaminetetraacetic acid (EDTA) disodium 
* Supported by Atomic Energy Commission contract  AT(04-3)-767 and a National De- 
fense Education Act fellowship. 
1 Abbreviations used in this paper: HBSS, Hanks' balanced salt solution; TC, thymocyte. 
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salt (6, 7). After filtration to remove the agarose beads, divalent cations were restored by the 
addition of CaCI2 in an amount equimolar to the previously added EDTA. The pH of the 
absorbed serum was brought to approximately 7.4 with 0.1 ~  NaOH. 0.5-ml aliquots of ab- 
sorbed sera were stored at -80°C until shortly before use. 
Sera from rats of strains WF or F344 were used unabsorbed and were diluted 1/4 in HBSS 
before storage at --80°C. 
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FIO.  1.  Killing of AKR/J TC by C3H/IIeJ anti-AKR/J serum. 100-pl aliquots of serum 
diluted  to  1/32  in HBSS were absorbed with the following numbers of thymocytes: none 
(O--O), 1 X  107 DA rat TC (0--0), 1 X  107 AKR/J TC  (AiA).  Complement source: 
1/12  agarose-absorbed rabbit serum. 
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FIG.  2.  Killing of  C3H/HeJ  TC  by  AKR/J  anti-C3H/HeJ  serum.  Symbols and  pro- 
cedure same as in Fig. 1. Absorption with 1 X  107 C3H/HeJ TC  ([3--[]). 
RESULTS 
Using AKR/J test cells and C3H/HeJ anti-AKR/J TC sera, rat thymocytes 
showed an intermediate  absorptive capacity, relative to AKR/J TC  (Fig. 1). 
However,  using  AKR/J  anti-C3H/HeJ  sera,  negligible  amounts  of  activity 
against  C3H/HeJ cells were removed by rat thymocytes while C3H/HeJ TC 
showed strong absorption (Fig. 2). Control absorptions with TC of the serum 
donor's strain  were also negative.  Cytotoxic autoantibodies  (8)  were not ob- 
served in this system. 1056  THETA-LIKE  ANTIGEN  IN RATS 
These absorption results were confirmed by the observation of direct killing 
of rat TC by mouse anti-0 serum in the presence of rat complement (Fig. 3). 
C3H/HeJ  anti-AKR/J  and  AKR/Cum  anti-AKR/J  TC  sera  were  both 
strongly cytotoxic for rat  TC  while  C3H/HeJ  and  AKR/Cum  normal  sera 
were not. Also negative against rat TC were AKR/J  anti-C3H/HeJ TC and 
AKR/J anti-AKR/Cum TC sera. 
The complement source used to demonstrate the presence of 0-like antigen 
on rat thymocytes was of critical importance, as may be seen from Figs. 4 and 
5. With rabbit complement, C3tt/I-IeJ anti-AKR/J TC serum showed only a 
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Fla. 3.  Complement-mediatedcytotoxicityof  WFratTCbyanti-0serum. Sera:C3H/HeJ 
anti-AKR/J TC  (El--l-q),  AKR/J anti-C3H/HeJ TC  (/x--A), C3H/HeJ  normal  serum 
(O--O). Complement source: 1/4 WF rat serum. 
Preliminary tissue  distribution  experiments indicated that rat thymus and 
brain  had  the  highest  absorptive  capacities  for  C3H/HeJ  anti-AKR/J  TC 
serum while rat liver, heart, testis, lung, skeletal muscle, erythrocytes, Peyer's 
patches,  spleen,  and  peripheral white  cells  showed  substantially less  absorp- 
tion. Based upon this observation, a developmental study of 0-like antigen in 
the rat nervous system was undertaken. 
Rats  were  killed  with  chloroform  and  perfused  with  0.85 %  NaC1.  The 
brains were dissected out, weighed,  and homogenized in saline so as to make 
suspensions  containing  100  mg  of  tissue  wet  weight/ml  of homogenate.  All 
homogenates  were  made  using  Potter-Elvehjem type  tissue  grinders.  Brain 
suspensions were stored at --20°C until used, at which time they were thawed 
and  rehomogenized.  Measured  aliquots  of  homogenate  were  centrifuged  at 
approximately 2150 g  for 5 min  and the supernatants discarded. 0.05-ml ali- 
quots of AKR/Cum anti-AKR/J TC serum diluted 1~56  in HBSS were then 
added. Absorptions were carried out for 30 min at room temperature with fre- 
quent stirring.  The  absorbed  sera were centrifuged at  2150 g for 5  min,  and TOMMY C.  DOUGLAS  1057 
the  supernatants  tested  for  residual  cytotoxic  activity  against  AKR/J  TC. 
Absorptive capacities were determined  from yon Krogh plots  (Fig.  6  [9,  10]). 
Fig.  7  shows that  an  approximately  logarithmic increase  in  the  rat  brain's 
theta-absorptive  capacity occurs between birth  and  approximately day 20,  at 
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FI6. 4.  Cytolysis  of WF  rat  thymocytes by anti-0  serum  and  agarose-absorbed  rabbit 
complement. Cells were incubated with or without anti-0 serum diluted  1/32 in HBSS. C3H/ 
HeJ anti-AKR/J serum (0--0), AKR/J anti-C3H/HeJ serum (0--0), no serum ([~--v1) 
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FIG. 5.  Cytolysis of WF rat thymocytes by anti-0 serum and unabsorbed rat complement. 
Symbols same as for Fig. 4. 
which point  the  slope  of the  curve  rapidly  declines.  No significant  difference 
in 0-absorptive capacity was observed between male and female rats. 
To date,  eight inbred rat strains have been tested for the presence of theta- 
like  antigen.  By both  absorption  and direct  cytotoxic tests,  thymocytes from 
rats of the ACI, BN, BUF, D, DA, F344, LEW, and WF strains  all expressed 
antigenic  determinants  cross-reactive  with  the  0-AKR mouse  antigen  (Table 
I). No significant cross-reactivity with the O-C3H antigen was observed. Wistar 
and Holtzman random-bred rats  also gave similar results. 1058  THETA-LIKE  ANTIGEN  IN  RATS 
DISCUSSION 
Quantitative absorption tests using mouse anti-0 sera and mouse thymocytes 
as  target  cells  showed  that  rats  of  the  inbred  strains  tested  all  expressed  an 
antigen which was strongly cross-reactive with the 0-AKR, but not the 0-C3H, 
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Fio.  6.  Determination  of  the theta-absorptive  capacities of WF rat brain  homogenates 
Postnatal  age:  8 days  (A--A),  18  days  (A--/x),  33  days  (0--0),  271  days  (O--C)). 
Serum: AKR/Cum anti-AKR/J TC diluted  1/256 in HBSS. Complement source: 1/18 agar- 
ose-absorbed rabbit  serum. 
cytotoxic  tests  were  performed  using  mouse  anti-0  sera  with  rat  thymocyte 
target cells. 
The AKR/Cum  mouse subline has been shown to be similar to the AKR/J 
subline  with reference  to several  alloantigenic markers  (Dr.  E.  A. Boyse, per- 
sonal  communication)  while  differing  at  the 0-locus  (11).  The cross-reactivity 
of AKR/Cum  anti-AKR/J  sera  with  rat  antigens  thus  argues  strongly  that 
the specificity detected  is indeed 0  and not some other antigen. 
As  has  been  observed  with  rat  lymphocytes  (12)  as  well  as  with  those  of 
other  species  (13),  the  complement source used  in  cytolytic assays  can be  of 
critical  importance.  Although  rat  strains  WF  and  F344  differ  at  three  of the TOMMY  C.  DOUGLAS  1059 
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FIc.  7.  Developmental appearance  of 0-like  specificity in  WF  rat  brain.  Absorptive ca- 
pacities are expressed as 0-absorptive units =  reciprocal of the number of milligrams of brain 
homogenate required  to produce 50% inhibition of cytotoxicity.  Serum: same as for Fig.  6. 
At  1  day,  theta-absorptive  capacity  <0.04. 
TABLE  I 
PerCentRatTC Kill~ by MouseAnti-OSera 
Serum 
c3~I/  A~R/  AKR/  AKR/  C3H/  HeJ anti-  AI~%/J  J anti-  J anti-  Rat strain  AKR/  Cuin anti-  HeJ NS 
None*  Cure NS  AKR/J  AKR/J  C3H/HeJ AKR/Cum 
ACI  18  12  58  11  77  17  19  15 
BN  20  8  60  7  78  22  27  19 
BUF  24  6  41  7  81  18  24  17 
F344  11  6  63  5  86  11  7  11 
LEW  13  9  64  3  90  11  9  12 
WF  14  10  77  10  81  16  16  14 
All sera used at 1/32 dilution in HBSS. Note that this serum concentration does not neces- 
sarily represent a "eytotoxic plateau" for the respective sera, but merely gives a  qualitative 
index of cytotoxic activity.  Complement source: WF serum diluted 1/4 in HBSS. 
* Preincubated with HBSS alone. 1060  THETA-LIKE  ANTIGEN  IN  RATS 
well-defined genetic  loci for  rat  cellular  antigens  (14),  their  sera  gave very 
similar results when used as complement sources for the immune cytolysis of 
thymocytes from six different strains of rats. The presence of rat natural anti- 
bodies (15)  apparently does not pose a problem in this system, and rat serum 
provides a convenient source of complement for such testing. 
In  addition  to  exhibiting  serological cross-reactivity with  0-AKR,  the  rat 
theta-like antigen also parallels the 0-antigen of the mouse in its tissue distri- 
bution and developmental kinetics (1, 16). Of particular in terest is its occurrence 
at high concentration in brain tissue. In both species, neonatal brain expresses 
little  or  no  antigen.  During  the  first  few  weeks  of  postnatal  life,  however, 
expression of the antigen rapidly rises to the adult level. 
The existence in rats of an antigenic system similar to the theta system of 
mice  provides  a  potentially valuable  resource for  structural  and  functional 
studies of both the immune system and the nervous system. It is recommended 
that the new rat antigen be designated 0-R based upon its homology with the 
mouse 0-antigen.  If allelic variants  are found,  they may be designated O-R  I, 
O-R  2, etc. 
Other rat  thymus  (17-20)  and brain  (21,  22)  antigens have been reported. 
Potworowski  and Nairn  (17,  18)  used BALB/c mouse anti-Lister hooded rat 
TC microsome sera whereas Waksman and his collaborators (19,  20) prepared 
anti-rat TC  sera in  rabbits.  Because BALB/c mice are homozygous for 0 cSs, 
anti-0-R-type antibodies might be expected to occur in sera raised against rat 
TC.  The  relationship  between 0-R  and  the  antigens  described by Waksman 
are somewhat more difficult to assess.  Activity paralleling that of anti-0 serum 
has  been  observed with  rabbit  anti-mouse  TC  and  rabbit  anti-mouse  brain 
sera, but such reagents have not distinguished the genetic variants revealed by 
alloantisera (23-26). 
SUMMARY 
A rat antigen system parallel to the mouse theta system has been described' 
All  rat  strains  tested  expressed  an  antigen  cross-reactive  with  the  0-AKR 
specificity of mice while none cross-reacted strongly with 0-C3H. The rat anti- 
gen may be demonstrated by either absorption or direct complement-mediated 
killing  of rat  thymocytes. Patterns  of organ  distribution  and  developmental 
appearance  in  the  nervous  system  of  rats  also  parallel  those  previously re- 
ported for theta in mice. 
I  wish to thank Dr. Ray D. Owen for his counsel and his help in preparation of the manu- 
script. I  also express thanks to Dr. David Dusenbery for his helpful discussions and to Eliza- 
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